Page last updated: 2024-08-23

idazoxan and Constriction, Pathological

idazoxan has been researched along with Constriction, Pathological in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Authier, N; Bertrand, M; Chapuy, E; Chenaf, C; Courteix, C; Eschalier, A; Gabriel, C; Libert, F; Marchand, F; Mocaƫr, E1
Bache, RJ; Laxson, DD1

Other Studies

2 other study(ies) available for idazoxan and Constriction, Pathological

ArticleYear
Agomelatine: a new opportunity to reduce neuropathic pain-preclinical evidence.
    Pain, 2017, Volume: 158, Issue:1

    Topics: Acetamides; Adrenergic alpha-2 Receptor Antagonists; Amines; Animals; Antineoplastic Agents; Constriction, Pathologic; Cyclohexanecarboxylic Acids; Diabetes Mellitus, Experimental; Disease Models, Animal; Excitatory Amino Acid Antagonists; Gabapentin; gamma-Aminobutyric Acid; Hyperalgesia; Hypnotics and Sedatives; Idazoxan; Male; Motor Activity; Neuralgia; Organoplatinum Compounds; Oxaliplatin; Pain Measurement; Rats; Rats, Sprague-Dawley; Thiophenes

2017
Coronary arteriolar vasoconstriction in myocardial ischaemia: coronary vasodilator reserve during ischaemia.
    European heart journal, 1990, Volume: 11 Suppl B

    Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Constriction, Pathologic; Coronary Circulation; Coronary Disease; Coronary Vessels; Dioxanes; Dogs; Heart Rate; Idazoxan; Physical Exertion; Prazosin

1990